Reduced Proteasomal Activity in Marrow Cells From Myelodysplastic Syndrome (MDS) Patients.

被引：0
|
作者：
Karabina, Stela [1 ]
Thanopoulou, Eleni [1 ]
Athanasiou, Sotirios D. [2 ]
Symeonidis, Argiris [3 ]
Zoumbos, Nicholas [4 ]
机构：
[1] Univ Patras, Sch Med, Div Hematol, Dept Internal Med, Patras, Greece
[2] Univ Patras, Dept Chem, Biochem Lab, Patras, Greece
[3] Univ Patras, Sch Med, GR-26110 Patras, Greece
[4] Univ Patras, Rion, Greece
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：706 / 707
页数：2
相关论文
共 50 条
  • [1] Thalidomide significantly modifies bone marrow microenvironment in myelodysplastic syndrome (MDS) patients.
    Alvi, S
    Borok, RZ
    Shaher, A
    Anthwal, S
    Shaikh, M
    Alvi, I
    Tahir, S
    John, P
    Shetty, V
    Galili, N
    Raza, A
    BLOOD, 2002, 100 (11) : 375A - 375A
  • [2] Transcriptomic Evaluation of CD34+Marrow Cells from Myelodysplastic Syndrome (MDS) Patients
    Im, Hogune
    Rao, Varsha
    Sridhar, Kunju Joshi
    Chen, Rui
    Mias, George
    Zhang, Yan
    Xiao, Li
    Snyder, Michael P.
    Greenberg, Peter L.
    BLOOD, 2014, 124 (21)
  • [3] Thalidomide significantly augments proliferation and cytokine secretion in bone marrow cultures established from myelodysplastic syndrome (MDS) patients.
    Alvi, S
    Anthwal, S
    Shaikh, M
    Shaher, A
    Shetty, V
    Mundle, S
    Reddy, P
    Allampallam, K
    Bi, SC
    Zorat, F
    Tamosveiciene, D
    Rasila, K
    Meagher, R
    Westbrook, C
    Galili, N
    Gezer, S
    Venugopal, P
    Borok, RZ
    Raza, A
    BLOOD, 2001, 98 (11) : 352A - 352A
  • [4] Ultrastructural evidence of previously unreported excessive apoptosis in high density bone marrow (BM) cells of myelodysplastic syndrome (MDS) patients.
    Shetty, V
    Hussaini, S
    Broady-Robinson, L
    Allampallam, K
    Ansaari, I
    Holtzclaw, J
    Mundle, S
    Mazzoran, L
    Zorat, F
    Payne, C
    Raza, A
    BLOOD, 1999, 94 (10) : 287B - 287B
  • [5] Research of subset and function of th cells in bone marrow of myelodysplastic syndrome patients.
    Wang, XL
    Wu, DP
    He, GS
    Miao, M
    Sun, AN
    BLOOD, 2005, 106 (11) : 308B - 308B
  • [6] ONCOPROTEIN EXPRESSION AND APOPTOSIS IN MYELODYSPLASTIC SYNDROME (MDS) MARROW-CELLS
    GREENBERG, PL
    GINZTON, N
    RAJAPAKSA, R
    BLOOD, 1994, 84 (10) : A54 - A54
  • [7] Cycling status of hemopoietic progenitor cells of the marrow from patients with myelodysplastic syndromes (MDS).
    Thanopoulou, E
    Galani, A
    Zoumbos, N
    BLOOD, 2003, 102 (11) : 326B - 326B
  • [8] Allogeneic stem cell transplantation results in our myelodysplastic syndrome (MDS) patients.
    Gurman, Gunhan
    Ataca, Pinar
    Aydin, Tolga
    Atilla, Erden
    Bozdag, Sinem Civriz
    Toprak, Selami Kocak
    Yuksel, Meltem Kurt
    Topcuoglu, Pervin
    Ozcan, Muhit
    Demirer, Taner
    Beksac, Meral
    Ilhan, Osman
    Akan, Hamdi
    Konuk, Nahide
    Arslan, Onder
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] A novel retinoid in bone marrow and plasma from control subjects and myelodysplastic syndrome patients.
    Besa, EC
    Rubin, S
    Canova, A
    Caputo, C
    Connolly, MM
    Piantedosi, R
    Blaner, W
    BLOOD, 1997, 90 (10) : 4030 - 4030
  • [10] Chromosomal abnormalities in marrow stromal cells from myelodysplastic syndromes (MDS)
    Flores-Figueroa, Eugenia
    Mayani, Hector
    BLOOD, 2006, 108 (12) : 3948 - 3948
12345